cycloleucine and fluorouracil

cycloleucine has been researched along with fluorouracil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Deng, W; Li, X; Liao, X; Tian, G; Yang, Z; Yi, J1
Hermans, JJ; Hop, WC; Incrocci, L; Jeekel, J; Kazemier, G; Morak, MJ; van Dekken, H; van der Gaast, A; van Eijck, CH1

Trials

1 trial(s) available for cycloleucine and fluorouracil

ArticleYear
Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Annals of surgery, 2008, Volume: 248, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Common Bile Duct Neoplasms; Cycloleucine; Disease Progression; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Lead; Male; Middle Aged; Mitoxantrone; Pancreatic Neoplasms; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Sulfides; Treatment Outcome

2008

Other Studies

2 other study(ies) available for cycloleucine and fluorouracil

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2003, Volume: 23, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization, Peripheral; Chemoembolization, Therapeutic; Cycloleucine; Female; Fibroblast Growth Factor 2; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Mitomycin; Vascular Endothelial Growth Factor A

2003